Diabetes Risk Evaluation and Microalbuminuria in Saskatchewan First Nations Peoples

NACompletedINTERVENTIONAL
Enrollment

95

Participants

Timeline

Start Date

September 30, 2001

Primary Completion Date

March 31, 2003

Study Completion Date

March 31, 2003

Conditions
HypertensionDiabetes Mellitus
Interventions
OTHER

Nurse administered treatment algorithm

Start with Irbesartan 150 mg/d; check BP in 6 wks, if BP \>=130/80 mm HF, 300 mg/d irbesartan; check BP at next visit, if BP\>= 130/80 mm Hg, add HCTZ 12.5 mg/d; check BP at next visit, if BP\>=130/80 mm Hg, add verapamil 180 mg/d; check BP at next visit, if BP\>=13/80 mm Hg, increase verapamil to 240 mg/d

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

collaborator

Pfizer

INDUSTRY

lead

Sunnybrook Health Sciences Centre

OTHER

NCT00741702 - Diabetes Risk Evaluation and Microalbuminuria in Saskatchewan First Nations Peoples | Biotech Hunter | Biotech Hunter